Two Sigma Investments LP cut its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 23.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 346,128 shares of the healthcare conglomerate’s stock after selling 108,823 shares during the period. Two Sigma Investments LP’s holdings in UnitedHealth Group were worth $55,394,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. The Manufacturers Life Insurance Company purchased a new position in shares of UnitedHealth Group during the third quarter worth approximately $391,839,000. State Street Corp increased its stake in UnitedHealth Group by 5.5% in the fourth quarter. State Street Corp now owns 44,601,975 shares of the healthcare conglomerate’s stock worth $7,138,090,000 after buying an additional 2,306,282 shares during the last quarter. Russell Investments Group Ltd. bought a new stake in UnitedHealth Group during the fourth quarter worth $313,747,000. Asset Management One Co. Ltd. increased its stake in UnitedHealth Group by 1,135.6% in the fourth quarter. Asset Management One Co. Ltd. now owns 1,754,953 shares of the healthcare conglomerate’s stock worth $281,003,000 after buying an additional 1,612,926 shares during the last quarter. Finally, Standard Life Investments LTD increased its stake in UnitedHealth Group by 103.9% in the third quarter. Standard Life Investments LTD now owns 1,960,547 shares of the healthcare conglomerate’s stock worth $274,486,000 after buying an additional 998,999 shares during the last quarter. 86.67% of the stock is currently owned by hedge funds and other institutional investors.
Shares of UnitedHealth Group Inc (NYSE:UNH) traded down 0.22% during midday trading on Friday, hitting $171.16. The stock had a trading volume of 2,981,797 shares. The firm’s 50-day moving average price is $167.19 and its 200-day moving average price is $157.47. UnitedHealth Group Inc has a 1-year low of $128.53 and a 1-year high of $172.62. The stock has a market cap of $162.80 billion, a price-to-earnings ratio of 23.61 and a beta of 0.68.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.17 by $0.20. The company had revenue of $48.72 billion for the quarter, compared to analyst estimates of $48.21 billion. UnitedHealth Group had a net margin of 3.92% and a return on equity of 21.20%. UnitedHealth Group’s revenue was up 9.4% compared to the same quarter last year. During the same period last year, the company posted $1.81 earnings per share. Analysts forecast that UnitedHealth Group Inc will post $9.51 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: “Two Sigma Investments LP Has $55.394 Million Stake in UnitedHealth Group Inc (UNH)” was originally published by BBNS and is the property of of BBNS. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at https://baseballnewssource.com/markets/unitedhealth-group-inc-unh-stake-decreased-by-two-sigma-investments-lp-updated-updated/525823.html.
A number of analysts have recently weighed in on the company. Vetr downgraded UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 10th. Deutsche Bank AG assumed coverage on UnitedHealth Group in a research report on Wednesday, April 5th. They set a “buy” rating and a $183.00 target price for the company. Stifel Nicolaus reiterated a “buy” rating and set a $185.00 target price on shares of UnitedHealth Group in a research report on Wednesday. Credit Suisse Group AG upped their target price on UnitedHealth Group from $185.00 to $188.00 and gave the company an “outperform” rating in a research report on Wednesday. Finally, Evercore ISI reiterated an “outperform” rating and set a $185.00 target price on shares of UnitedHealth Group in a research report on Wednesday. One analyst has rated the stock with a hold rating and twenty-three have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $181.05.
In other UnitedHealth Group news, Director Michele J. Hooper sold 15,000 shares of UnitedHealth Group stock in a transaction on Thursday, March 16th. The shares were sold at an average price of $170.89, for a total value of $2,563,350.00. Following the transaction, the director now directly owns 35,941 shares of the company’s stock, valued at $6,141,957.49. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction on Tuesday, January 31st. The stock was sold at an average price of $161.68, for a total transaction of $1,616,800.00. Following the completion of the transaction, the director now directly owns 1,921,191 shares in the company, valued at $310,618,160.88. The disclosure for this sale can be found here. Insiders sold 35,310 shares of company stock worth $5,855,416 over the last ninety days. Corporate insiders own 1.65% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with our FREE daily email newsletter.